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Physical Activity in Older Men: Longitudinal Associations with
Inflammatory and Hemostatic Biomarkers, N-Terminal
Pro-Brain Natriuretic Peptide, and Onset of Coronary Heart
Disease and Mortality
Barbara J. Jefferis, PhD,*† Peter H. Whincup, PhD,‡ Lucy T. Lennon, MSc,*
Olia Papacosta, MSc,* and S. Goya Wannamethee, PhD*
OBJECTIVES: To examine associations between habitual
physical activity (PA) and changes in PA and onset of cor-
onary heart disease (CHD) and the pathways linking PA
to CHD.
DESIGN: British Regional Heart Study population-based
cohort; men completed questionnaires in 1996 and 1998
to 2000, attended rescreen in 1998 to 2000, and were fol-
lowed up to June 2010.
SETTING: Community.
PARTICIPANTS: Of 4,252 men recruited from primary
care centers (77% of those invited and eligible) who were
rescreened in 1998 to 2000, 3,320 were ambulatory and
free from CHD, stroke, and heart failure and participated
in the current study.
MEASUREMENTS: Usual PA (regular walking and
cycling, recreational activity and sport). Outcome was first
fatal or nonfatal myocardial infarction.
RESULTS: In 3,320 ambulatory men, 303 first and 184
fatal CHD events occurred during a median of 11 years of
follow-up; 9% reported no usual PA, 23% occasional PA,
and 68% light or more-intense PA. PA was inversely asso-
ciated with novel risk markers C-reactive protein, D-dimer,
von Willebrand Factor and N-terminal pro-brain natri-
uretic peptide (NT-proBNP). Compared with no usual PA,
hazard ratios (HRs) for CHD events, adjusted for age and
region, were 0.52 (95% confidence interval (CI) = 0.34–
0.79) for occasional PA, 0.47 (95% CI = 0.30–0.74) for
light PA, 0.51 (95% CI = 0.32–0.82) for moderate PA,
and 0.44 (95% CI = 0.29–0.65) for moderately vigorous
or vigorous PA (P for linear trend = .004). Adjustment for
established and novel risk markers somewhat attenuated
HRs and abolished linear trends. Compared with men
who remained inactive, men who maintained at least light
PA had an HR for CHD events of 0.73 (95% CI = 0.53–
1.02) and men whose PA level increased had an HR of
0.86 (95% CI = 0.55–1.35).
CONCLUSION: Even light PA was associated with signif-
icantly lower risk of CHD events in healthy older men,
partly through inflammatory and hemostatic mechanisms
and cardiac function (NT-proBNP). J Am Geriatr Soc
62:599–606, 2014.
Key words: physical activity; CHD; inflammation;
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Coronary heart disease (CHD) rates rise rapidly withage, so there is a pressing need to understand the
effect of modifiable behaviors such as physical activity
(PA) for primary prevention of CHD in older adults. This
is particularly important because PA declines to low levels
in older age,1 and (in contrast with middle age) the quan-
tity and intensity of PA required for primary prevention of
CHD in older adults remains unclear.2 A recent meta-
analysis concluded that the most-active adults were at
30% to 35% lower risk of CHD and that those who were
moderately active were at 20% to 25% lower risk of
developing CHD than those who were the least active,2
but data on older adults are sparse. Only two of the 30
studies included participants with median age of 65 and
older at baseline, yet in the INTERHEART study, PA was
found to protect against CHD more strongly in older than
in younger men.3 Furthermore, in older age, the role of
established (blood pressure, lipids, adiposity) and novel
risk factors as mediators between PA and CHD is not
clear. C-reactive protein (CRP), a marker of inflammation
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that is particularly strongly linked to fatal CHD in older
adults,4 von Willebrand factor (vWF), a marker of
endothelial dysfunction; D-dimer, a marker of fibrinolytic
activity; and N-terminal pro-brain natriuretic peptide
(NT-proBNP), a marker of cardiac injury, are all
associated with PA levels5–8 and prospectively associated
with CHD9–11 or cardiovascular disease (CVD)6 and heart
failure12 in healthy older adults. Given that levels of these
markers rise with age, they may be important mediators
between PA and CHD risk at older ages. There is some
evidence that inflammation is an important mediator
between PA and composite end points (including myocar-
dial infarction (MI), coronary revascularization, stroke,
and heart failure),13,14 but the mediating role of other
markers is less clear. Associations between habitual PA
and onset of CHD in healthy community-dwelling older
men, whether changes in PA levels in later life are
associated with onset of CHD, and the pathways linking
PA to CHD were therefore examined. All-cause mortality
was also examined as an end point.
METHODS
The British Regional Heart Study is a prospective cohort
of 7,735 men aged 40 to 59 in 1978 to 1980 recruited
from a single primary care center in each of 24 British
towns. Men were followed up for cardiovascular morbid-
ity and all-cause mortality. At age 56 to 74 (in 1996),
men completed a postal questionnaire that collected
detailed medical history and social, demographic, and
health behavior data. At age 60 to 79 (in 1998–2000),
4,252 participants attended for follow-up measurements
(77% response rate)15 and completed further question-
naires. Nurses took anthropometric measures and an elec-
trocardiogram (including resting heart rate) and recorded
blood pressure and lung function (forced vital capacity
(FVC) and forced expiratory volume in 1 second
(FEV1)).
15 Chronic obstructive airway disease was defined
as a ratio of FEV1 to FVC of less than 0.70. Fasting
venous blood samples were collected and analyzed for lip-
ids, vitamin C, and creatinine.16,17 Estimated glomerular
filtration rate (eGFR) was estimated from serum creatinine
using the Modification of Diet in Renal Disease equa-
tion,18 and participants with an eGFR less than 60 were
categorized as having chronic kidney disease. Plasma lev-
els of D-dimer and vWF antigen were measured using
enzyme-linked immunosorbent assays, and CRP was
assayed using ultrasensitive nephelometry. NT-proBNP
was measured using the electrochemiluminescence
method.6 Presence of depression was identified according
to current antidepressant use reported in questionnaires
(British National Formulary Code 4.3). Preexisting physi-
cian-diagnosed CHD, stroke, or diabetes mellitus (DM)
was identified from questionnaire data and general practi-
tioner records according to whether men reported that a
doctor had ever told them that they had angina pectoris
or MI (heart attack, coronary thrombosis), stroke, “other
heart trouble,” or DM in 1998 to 2000 or had had a
major nonfatal MI or stroke event or been diagnosed with
DM, based on the regular surveillance of general practi-
tioner’s records. Prevalent DM was defined as doctor diag-
nosis of DM or fasting glucose of 7 mmol/L or greater
(World Health Organization (WHO) criteria) at the 1998
to 2000 examination. Nine hundred twenty-eight individu-
als with a history of doctor-diagnosed CHD, stroke, or
heart failure and five nonambulatory individuals were
excluded to reduce the risk of reverse causality. All rele-
vant local research ethics committees provided ethical
approval, and all men provided informed written consent
to the investigation.
Physical Activity
In 1996 and in 1998 to 2000, men self-reported usual PA
under the headings of regular walking or cycling, recrea-
tional activity, and sporting (vigorous) activity. Regular
walking and cycling related to weekday journeys that
included travel to and from work. Recreational activity
included gardening, pleasure walking, and do-it-yourself
jobs. Sporting activity included running, golf, swimming,
tennis and sailing. A PA score (validated in relation to
heart rate and FEV1
5,19) was derived for each man. Scores
were assigned for each type of activity and duration on the
basis of the intensity and energy demands of the activities
reported based on Minnesota intensity codes. Men were
categorized into six groups based on their total score: inac-
tive (0–2); occasional (3–5), regular walking or recrea-
tional activity only; light (6–8), more frequent recreational
activities, sporting exercise less than once per week, or
regular walking plus some recreational activity; moderate
(9–12), cycling or very frequent weekend recreational
activities plus regular walking or sporting activity once per
week; moderately vigorous (13–20), sporting activity at
least once per week or frequent cycling plus frequent
recreational activities or walking or frequent sporting
activities only; and vigorous (>21), very frequent sporting
exercise or frequent sporting exercise plus other recrea-
tional activities. The moderately vigorous and vigorous
groups were combined because of low numbers of CHD
events in these groups. The total score for each man is not
a measure of total time spent doing PA but a relative
measure of how much PA has been performed.
CHD Mortality and Morbidity
All men were followed up for all-cause mortality and first
fatal or nonfatal MI occurring between the 1998 to 2000
survey and June 2010. All deaths were ascertained through
the National Health Services Central Registers, MI deaths
were those with death certificates with International Clas-
sification of Disease (ICD), Ninth Revision, codes 410 to
414 and ICD, Tenth Revision, codes I21 to I23 and I252.
Nonfatal events were recorded from reviews every 2 years
of primary care notes (which include correspondence and
diagnoses from secondary care).15 MI was reported as
heart attack or coronary thrombosis, diagnosed in accor-
dance with WHO criteria.20
Statistical Methods
Means, medians, or proportions of behavioral and demo-
graphic factors selected a priori were calculated according
to usual PA level in 1998 to 2000. Trends across the five
PA categories were tested using linear regression models
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for continuous variables and chi-square tests for categori-
cal variables.
Cox regression models were used to estimate associa-
tions between 1998 to 2000 PA score and CHD risk or
all-cause mortality. Survival times were censored at date of
MI, death from any cause, or end of follow-up period,
whichever occurred first. The time origin was date of
examination in 1998 to 2000. The HRs for categories of
PA in 1998 to 2000 were estimated, and then trends were
tested using the continuous PA score, adjusted for age and
region of residence. Models were adjusted for covariates
associated with CHD risk and PA: first established social
and behavioral risk factors, then biological risk markers,
then markers of inflammation and coagulation (CRP,
vWF, D-dimer), and then NT-proBNP were added sequen-
tially. In sensitivity analyses, the first 2 years of follow-up
were excluded. Population attributable risk percentage was
calculated as (Pe (RRe  1)/[1 + Pe (RRe  1)]) 9 100
using the hazard ratio (HR) comparing none or occasional
PA with light or more as RRe and the prevalence of no or
occasional activity as Pe.
To investigate changes in PA levels between 1996 and
1998 to 2000, the lowest two categories (none and occa-
sional activity) were compared with the highest four (light
through vigorous activity). Men in the lower PA groups
walked regularly or participated in some recreational activ-
ity, in the more-active groups (from light upward), they
participated in these activities more frequently, as well as
some kind of sporting exercise. Means, medians, or pro-
portions of behavioral and demographic factors selected a
priori were calculated according to change in PA level.
Cox regression models were used to estimate associations
between change in PA level from 1996 to 1998 to 2000
and risk of CHD or mortality, following the same analysis
plan as for PA in 1998 to 2000.
RESULTS
In 1998 to 2000, of 4,252 men aged 60 to 79 who
attended their primary care center for rescreen as part of
the established British Regional Heart Study,15 4,097
(96%) reported complete questionnaire data on usual PA
levels. Nine hundred twenty-eight participants with a his-
tory (self-report of physician diagnosis or medical record)
of CHD, stroke, or heart failure and a further five partici-
pants who used a wheelchair were excluded, leaving an
analysis sample of 3,320 men. Of the 3,320 men, mean
age at rescreen (1998–2000) was 68.3  5.4. There were
303 first (fatal or nonfatal) CHD events during a median
follow-up of 10.9 years (32,070 person-years, 9.4 cases
per 1,000 person-years), to June 2010, and 184 fatal CHD
events during a median follow-up of 11.0 years (32,712
person-years, 5.6 cases per 1,000 person-years).
PA Levels and Their Correlates
The prevalence of PA is reported in Table 1. More-active
men were more likely to be from a nonmanual social class
and to drink 15 U/wk of alcohol or more and less likely to
smoke. They had lower prevalence of chronic obstructive
pulmonary disease (COPD) and diabetes mellitus; lower
mean body mass index (BMI) and waist circumference;
lower fasting triglyceride, total cholesterol, CRP, vWF,
D-dimer, and NT-proBNP levels; and higher plasma vitamin
C, FEV1, and high-density lipoprotein cholesterol levels.
PA and CHD Morbidity and Mortality
The HRs for CHD decreased with increasing PA level (P
linear trend = .004, Table 2). Compared with men report-
ing no usual leisure time PA, men reporting occasional,
light, moderate, and moderately vigorous or vigorous
activity had age- and region-adjusted HRs for first CHD
event of 0.52 (95% CI = 0.34–0.79), 0.47 (95%
CI = 0.30–0.74), 0.51 (95% CI = 0.32–0.82) and 0.44
(95% CI = 0.29–0.65), respectively. The greatest incre-
mental benefit was from occasional activity. Rerunning
models with occasional activity as the reference group did
not show evidence of further benefit for more-vigorous
activities (data not shown). Adjustment for established
behavioral and biological risk factors, including diabetes
mellitus, renal function, and depression (Table 2, Model
2), attenuated the associations to a small degree, but the
linear trend remained. Further adjustments for CRP,
D-dimer, and vWF (Model 3) and NT-proBNP (Model 4)
minimally reduced the estimates, and the strong protective
effect of PA against CHD events remained, although the
linear trend was no longer evident after adjustment for
NT-proBNP. Similar patterns were observed for fatal
CHD events. The age- and region-adjusted HRs for fatal
CHD decreased with increasing PA levels, (P for linear
trend <.005), (Table 2). For fatal CHD, the greatest incre-
mental benefit was from light activity. Rerunning models
with occasional activity as baseline did not show evidence
of further benefit from moderately vigorous and vigorous
activity (data not shown). Adjustments for CRP, D-dimer,
and vWF (Model 3) and NT-proBNP (Model 4) minimally
reduced the estimates, and the linear trends were attenu-
ated. The data for all-cause mortality showed a similar
pattern to first CHD events, with increasing level of PA
strongly protective against mortality. Adjustment for
COPD rather than FEV1 did not change the pattern of
results (data not shown).
Change in PA Level and CHD Risk
Ninety percent (2,715/3,008) of men included in analyses
of PA in 1998 to 2000 had also reported PA levels in a
questionnaire 4 years earlier, in 1996; 22% were consis-
tently inactive (did no or only occasional PA) in 1996 and
1998 to 2000, 55% were consistently active (light, moder-
ate, or more-vigorous habitual PA) in 1996 and 1998 to
2000, 14% participated in at least light activity (light,
moderate, or more-vigorous PA), and 9% who were active
in 1996 had become inactive by 1998 to 2000 (Table 3).
Compared to men who were inactive at both times, men
who had become active by 1998 to 2000 or were active at
both times were younger and more likely to be from a
nonmanual social class, drink alcohol regularly, never
smoke, not use antidepressants, not have COPD or chronic
kidney disease. They were more likely to have higher
plasma vitamin C levels; lower BMI, waist circumference
and, heart rate; lower triglyceride, CRP, vWF, D-dimer,
and NT-proBNP levels; and higher FEV1 and eGFR.
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Compared with the baseline group (inactive at both
times), HRs for CHD events for men who became inac-
tive were similar to HRs for CHD events for those who
remained inactive (HR = 0.87, 95% CI = 0.53–1.45), and
likewise for men who became active (HR = 0.86, 95%
CI = 0.55–1.35), there was a trend toward protection for
men who remained active at both times (HR = 0.73,
95% CI = 0.53–1.02) (Table 4). Equivalent values for
fatal CHD were 0.58 (95% CI = 0.29–1.17), 0.67 (95%
CI = 0.37–1.21), and 0.58 (95% CI = 0.38–0.89), respec-
tively. Adjustment for established risk factors (Model 2)
attenuated the HR for remaining active compared with
remaining inactive, but the direction of the estimate
toward lower risk remained evident even with adjust-
ments for CRP, D-dimer, and vWF (Model 3) or
NT-proBNP (Model 4). For all-cause mortality the HR
for events in men who became less active was similar to
the HR for events of men who remained inactive. There
was a protective effect in men who became more active
(HR = 0.65, 95% CI = 0.50–0.85) and in men who
remained consistently active (HR = 0.62, 95% CI = 0.51–
0.74), adjusted for age and region, which was robust to
adjustment in Model 2 and was little attenuated further
by addition of CRP, vWF, and D-dimer (Model 3) or
NT-proBNP (Model 4). Adjustment for COPD rather
than FEV1 did not change the pattern of results (data not
shown).
In sensitivity analyses, conclusions were not altered
when the first 2 years of follow-up were excluded. If the
30.1% of men performing no or occasional activity were
light or more-active, the population attributable risk per-
centage would be a 14% reduction in CHD deaths and
13% in all-cause mortality.
DISCUSSION
This population-based study of healthy older men found
that men who reported even light PA in later life had an
approximately 50% lower risk of fatal or nonfatal CHD
events than inactive men. There was little evidence of fur-
ther protection from more-intense PA levels. There was a
tendency for lower risk of fatal CHD in men who
increased their habitual PA levels from occasional to at
least light activity and clearer evidence of substantially
lower risk of fatal CHD in those who were active (light
or more intense activity) at both times than in those who
remained inactive in later life (between the ages of late
50s and 70s). Associations between PA and CHD were
robust to adjustment for important established demo-
graphic, behavioral, and biological risk factors. There was
Table 1. Characteristics of Men According to Physical Activity Score (N = 3,320 Men without Preexisting
Coronary Heart Disease, Stroke, or Diabetes Mellitus)
Characteristic N
None,
n = 310
Occasional,
n = 764
Light,
n = 640
Moderate,
n = 514
Moderately
Vigorous and
Vigorous,
n = 1,092 P (Trend)
Age 3,320 69.6 68.8 68.5 67.6 67.9 <.001
Manual social class, n (%) 3,113 170 (55) 403 (53) 353 (55) 265 (52) 463 (42) <.001
>15 U/wk of alcohol, n (%) 3,246 39 (13) 119 (16) 92 (15) 91 (18) 178 (17) <.001
Current smoker, n (%) 3,316 71 (23) 110 (14) 92 (14) 63 (12) 95 (9) <.001
Use of antidepressants, n (%) 3,320 16 (5) 26 (3) 14 (2) 13 (3) 25 (2) .05
Plasma vitamin C, lmol/L, geometric mean 3,090 18.2 20.1 22.2 22.2 24.5 <.001
Body mass index, kg/m2, meana 3,311 27.9 27.0 26.6 26.7 26.5 <.001
Waist circumference, cm, meana 3,304 100.7 98.0 96.7 96.7 95.1 <.001
Total cholesterol, mmol/L, mean 3,170 5.9 6.0 6.1 6.1 6.1 .19
High-density lipoprotein cholesterol, mmol/L,
mean
3,150 1.3 1.3 1.3 1.3 1.4 <.001
Triglycerides, mmol/L, geometric meanb 3,169 0.5 0.5 0.5 0.4 0.4 <.001
Systolic blood pressure, mmHg, meana,b 3,307 150.4 150.8 150.8 148.3 149.5 .149
Diastolic blood pressure, mmHg, meana,b 3,307 84.6 85.5 86.4 85.6 85.7 .619
Forced expiratory volume in 1 second, L,
meana,c
3,187 2.0 2.1 2.2 2.4 2.4 <.001
Diabetes mellitus, n (%) 3,320 47 (15) 95 (12) 70 (11) 38 (7) 95 (9) .001
Chronic obstructive pulmonary disease,
n (%)
3,297 86 (28) 212 (28) 181 (28) 107 (21) 236 (22) <.001
Heart rate, beats/min, mean 3,312 70.0 67.2 66.5 64.6 63.6 <.001
Estimate glomerular filtration rate, mean 3,172 71.9 72.5 73.3 73.9 73.4 .06
Renal dysfunction, n (%) 3,127 47 (16) 94 (13) 65 (11) 48 (10) 102 (10) .02
C-reactive protein, mg/L, geometric mean 3,186 2.7 1.8 1.6 1.5 1.3 <.001
von Willebrand factor, IU/dL, mean 3,208 151.6 139.2 134.8 135.1 133.5 <.001
D-dimer, ng/mL, geometric mean 3,207 109.9 90.0 81.5 73.7 73.7 <.001
N-terminal pro-brain natriuretic peptide,
pg/mL, geometric mean
2,986 121.5 90.0 90.0 81.5 73.7 <.001
aAdjusted for interobserver variation.
bAdjusted for time of day.
cAdjusted for height squared.
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little evidence that novel biomarkers of inflammation and
fibrinolytic activity or cardiac injury were important medi-
ators of the association between PA and nonfatal CHD,
although there was some evidence that they mediated the
association between PA and fatal CHD events and all-
cause mortality. This study is one of few prospective
cohort studies relating PA in later life and change in PA
to CHD risk in older adults. It extends prior findings from
largely middle-aged population samples into an older age
group and adds new information about mediating path-
ways between PA and CHD risk.
PA at One Time Point in Later Life: Relationship to
CHD Risk
Most evidence about the shape of the dose-response curve
between PA and CHD relates to middle-aged rather than
older adults.2 In the current sample of older adults, poten-
tially beneficial effects of even occasional and light PA on
risk of fatal or nonfatal CHD were found and that the
greatest incremental benefits may accrue from light activ-
ity. Occasional PA in the current study included regular
walking and some recreational activity but not vigorous
sporting activity. The results fit with recent evidence that
lighter activities are protective against CHD, suggesting
that some activity is better than none.2 Light activity or
more was associated with approximately half the risk of
CHD mortality and morbidity, which was estimated as
greater than 30% to 35% in a systematic review largely
using data from middle-aged adults.2 Associations with
nonfatal CHD were of similar magnitude to those reported
in the British Regional Heart Study cohort when they were
20 years younger, although the benefits from moderate
and moderate to vigorous activity may be somewhat stron-
ger in middle age.19 Regular walking has been associated
with halving the risk of CHD events in elderly men21 and
women,22 and 40% less CVD mortality was reported for
older adults performing more than 30 minutes of activity
per day (including low-intensity stretching exercises and
walking slowly) than for those performing none.23 PA has
substantial potential to reduce avoidable CHD deaths in
elderly adults; in the current sample, if those who were
less active became at least light active (regular daily walk-
ing and some recreational activity, e.g., gardening, yard
work, household chores), a 14% reduction in CHD mor-
tality would be expected.
Table 2. Risk of Coronary Heart Disease (CHD) Mortality in Men According to Physical Activity Score: 1998–
2000
Outcome
None,
n = 233
Occasional,
n = 604
Light,
n = 502
Moderate,
n = 407
Moderately
Vigorous and
Vigorous,
n = 895
Total,
N = 2,641 P (Trend)
First CHD event (fatal or nonfatal)
CHD fatal or nonfatal
events, n
37 55 43 35 66 236
CHD event
rate/1,000
18.9 9.5 8.7 8.6 7.4 9.2
HR (95% CI)
Model 1 1 0.52 (0.34–0.79) 0.47 (0.30–0.74) 0.51 (0.32–0.82) 0.44 (0.29–0.65) .004
Model 2 1 0.53 (0.34–0.81) 0.48 (0.31–0.75) 0.55 (0.34–0.89) 0.48 (0.31–0.73) .02
Model 3 1 0.54 (0.35–0.83) 0.50 (0.32–0.78) 0.57 (0.36–0.93) 0.50 (0.33–0.76) .04
Model 4 1 0.53 (0.35–0.81) 0.50 (0.32–0.78) 0.57 (0.35–0.92) 0.51 (0.33–0.78) .05
Fatal CHD
CHD fatal events, n 21 39 23 19 34 136
CHD mortality/1,000 10.3 6.6 4.5 4.5 3.7 5.1
HR (95% CI)
Model 1 1 0.68 (0.40–1.16) 0.46 (0.26–0.84) 0.55 (0.29–1.02) 0.43 (0.25–0.75) .005
Model 2 1 0.73 (0.42–1.25) 0.51 (0.28–0.94) 0.67 (0.35–1.27) 0.52 (0.29–0.92) .04
Model 3 1 0.78 (0.45–1.36) 0.57 (0.31–1.05) 0.74 (0.39–1.41) 0.58 (0.33–1.03) .09
Model 4 1 0.76 (0.44–1.32) 0.57 (0.31–1.05) 0.73 (0.38–1.39) 0.61 (0.34–1.08) .14
All-cause mortality
Deaths, n 110 192 118 88 202 710
Mortality/1,000 54.1 32.7 23.3 21.1 22.2 27.0
HR (95% CI)
Model 1 1 0.61 (0.48–0.77) 0.43 (0.33–0.56) 0.44 (0.33–0.59) 0.45 (0.35–0.57) <.001
Model 2 1 0.67 (0.53–0.85) 0.49 (0.38–0.65) 0.53 (0.40–0.71) 0.57 (0.45–0.73) <.001
Model 3 1 0.71 (0.56–0.91) 0.55 (0.42–0.71) 0.58 (0.43–0.78) 0.63 (0.49–0.81) .003
Model 4 1 0.69 (0.54–0.88) 0.52 (0.40–0.68) 0.56 (0.42–0.75) 0.63 (0.49–0.80) .004
Model 1 = age and region.
Model 2 = model 1 plus alcohol intake, smoking history, plasma vitamin C, social class, total cholesterol, high-density lipoprotein cholesterol, triglyce-
rides, systolic blood pressure, waist circumference, forced expiratory volume in 1 second, estimated glomerular filtration rate, depression, and diabetes
mellitus.
Model 3 = Model 2 plus C-reactive protein, von Willebrand factor, and D-dimer.
Model 4 = Model 2 plus N-terminal pro-brain natriuretic peptide.
HR = Hazard Ratio; CI = Confidence Interval.
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Changes in PA in Later Life: Relationship to CHD Risk
In the present study, men who remained active and those
who became active had lower CHD risk (particularly for
fatal events) than those who remained or became inactive.
A protective effect of increasing PA level in older age on
all-cause or CHD mortality is reported in a few studies of
general populations,24–27although not all report conclusive
findings.28 An investigation of this cohort when younger
found that increasing PA levels during middle age or main-
taining at least light activity was associated with lower all-
cause and CVD mortality than persistently low activity
levels.29
Pathways
The association between PA and fatal CHD operated
through established risk factors, consistent with expecta-
tions from studies of middle-aged adults,19 but their
explanatory power was small, suggesting that PA affects
CHD risk in older adults by other means. Previous studies
suggest that inflammatory markers may play an important
role in mediating the effects of PA on CHD in middle-aged
populations,13,14,30 and the current study found that
adjustment for CRP, vWF, and D-dimer (which have pre-
viously been linked to CHD risk4,9–11,31 and PA levels5,32)
partially explained associations between PA and CHD.
NT-proBNP was included to indicate presence of cardiac
injury and level of cardiac function. Some evidence was
found that NT-proBNP may be important in explaining
the onset of fatal CHD events, which fits with other evi-
dence linking NT-proBNP more strongly to CHD mortal-
ity than morbidity.6
Strengths and Limitations
This study benefits from prospective data with high fol-
low-up rates, validated MI events, and a PA score vali-
dated against biological measures (e.g., FEV1 and heart
rate5,19). The mediating role of a wide range of estab-
lished and novel biological risk factors that may be on
the causal pathway between activity and CHD risk was
investigated. The possibility of residual confounding can-
not be excluded, but many important behavioral and
social confounders were adjusted for. To reduce risks of
reverse causality, men with preexisting CHD, stroke, or
heart failure or limited mobility were excluded because
they have high risk of mortality and are likely to limit
their PA because of their prior health, and the first
2 years of follow-up were excluded in a sensitivity analy-
sis. The data about PA at more than one time point in
later life enabled investigation of how changes in PA were
Table 3. Associations Between Changes in Physical Activity Score Between 1996 and 2000 and Demographic
Variables (N = 3,001)
Characteristic Total, n
Inactive at
Both Times
Became
Inactive by
1998–2000
Became
Active by
1998–2000
Active at
Both Times
P (Linear
Trend)
Participants, n (%) 3,001 680 (22) 274 (9) 411 (14) 1,636 (55)
Age, mean 3,001 68.7 69.0 67.9 67.9 <.001
Manual social class, n (%) 2,995 342 (51) 149 (54) 231 (56) 728 (45) <.001
>15 U/wk of alcohol, n (%) 2,929 98 (15) 47 (18) 55 (14) 272 (17) <.001
Current smoker, n (%) 2,997 109 (16) 40 (15) 53 (13) 159 (10) <.001
Current use of antidepressants, n (%) 3,001 33 (5) 5 (2) 9 (2) 39 (2) .005
Vitamin C, lmol/L, geometric mean 2,796 20.49 20.70 22.65 24.05 .001
Body mass index, kg/m2a 2,994 27.34 27.08 26.87 26.45 <.001
Waist circumference, cma 2,987 99.02 97.84 97.04 95.65 <.001
Total cholesterol, mmol/L 2,866 6.03 6.09 6.05 6.09 .21
High-density lipoprotein cholesterol, mmol/L 2,850 1.30 1.34 1.33 1.35 .00
Triglycerides, mmol/L, geometric meanb 2,865 0.54 0.42 0.46 0.45 .01
Systolic blood pressure, mmHga,b 2,989 150.2 151.0 149.0 149.7 .57
Diastolic blood pressure, mmHga,b 2,989 85.2 85.2 85.5 86.0 .08
Forced expiratory volume in 1 second, La,c 2,884 2.12 2.18 2.28 2.37 <.001
Diabetes mellitus, n (%) 3,001 100 (15) 29 (11) 42 (10) 142 (9) <.001
Chronic obstructive pulmonary disease, n (%) 2,983 187 (28) 76 (28) 113 (28) 365 (22) .007
Heart rate, beats/min 2,993 67.9 68.1 65.3 64.5 <.001
Estimated glomerular filtration rate 2,868 72.4 72.3 72.7 73.5 .03
Chronic kidney disease, n (%) 2,825 89 (14) 31 (12) 49 (13) 146 (9) .01
C-reactive protein, mg/L, geometric mean 2,882 2.10 1.93 1.67 1.39 <.001
von Willebrand factor, IU/dL 2,903 142.3 139.7 139.7 132.2 <.001
D-dimer, ng/mL, geometric mean 2,902 90.0 90.9 77.5 73.0 <.001
N-terminal pro-brain natriuretic peptide, pg/mL,
geometric mean
2,705 90.9 99.5 84.8 76.7 <.001
Inactive = no or occasional usual physical activity; active = light, moderate, moderately vigorous, or vigorous physical activity, reported at 1996 and 1998
to 2000.
aAdjusted for interobserver variation.
bAdjusted for time of day.
cAdjusted for height squared.
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related to incidence of CHD, although small numbers of
CHD events in one of the change groups were a limita-
tion. Data were lacking on cardiorespiratory and muscu-
lar fitness, which are shown to be related to onset of
CVD and to CVD risk factors.33–35 The current study
was limited to healthy men, so results cannot be general-
ized to older women or those with preexisting CVD,
although the sample was socioeconomically representative
of older men in the United Kingdom and had exception-
ally high follow-up rates.
In an observational study, it is not possible to estab-
lish causality of the associations observed between PA and
CHD, but men with prevalent CHD, stroke, and heart
failure were excluded to minimize the chance that any
findings were due to men reducing their PA levels because
of presence of disease (reverse causality). The analyses
were adjusted for a wide range of confounding factors,
and data on PA at more than one time point in later life
were also included, which enabled how changes in PA
were related to incidence of CHD to be examined, which
gives a stronger level of evidence than using PA from just
one time point. Finally, the findings suggesting that PA
may protect against onset of CHD morbidity and total
mortality fit with a large body of research (clinical and
observational) that suggests that PA protects against onset
of CHD.36
CONCLUSION
PA in later life is potentially important in primary preven-
tion of CHD and all-cause mortality in older men. Even
very modest levels of PA were associated with approxi-
mately half the risk of CHD morbidity and all-cause mor-
tality, in part mediated by the beneficial effects on
adiposity and blood lipids, inflammatory and hemostatic
mechanisms, and cardiac injury (NT-proBNP). Taking up
PA in later life was associated with approximately one-
third lower risk of all-cause mortality, although strong evi-
dence of reduction in CHD events was not found (although
numbers were low). There was some evidence that remain-
ing active in later life protected against CHD and all-cause
mortality. Promotion of PA in later life is therefore impor-
tant. Preventing the age-related declines in PA levels
observed in many populations could markedly reduce
CHD risk in older adults, who are a high-risk group.
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Table 4. Risk of Coronary Heart Disease (CHD) Mortality in Men According to Change in Physical Activity Score
Between 1996 and 2000
Outcome
Inactive at Both
Times, n = 525
Became Inactive by
1998–2000, n = 221
Became Active by
1998–2000, n = 331
Active at Both
Times, n = 1,316
Total,
N = 2,393
First CHD event (fatal or nonfatal)
CHD fatal or nonfatal events, n 54 21 30 101 206
CHD event rate/1,000 11.0 10.1 9.3 7.7 8.8
HR (95% CI)
Model 1 1 0.87 (0.53–1.45) 0.86 (0.55–1.35) 0.73 (0.53–1.02)
Model 2 1 0.84 (0.51–1.41) 0.90 (0.57–1.42) 0.78 (0.55–1.09)
Model 3 1 0.84 (0.50–1.41) 0.92 (0.58–1.44) 0.79 (0.56–1.12)
Model 4 1 0.87 (0.52–1.46) 0.92 (0.59–1.45) 0.81 (0.58–1.15)
Fatal CHD
CHD fatal events, n 36 10 16 52 114
CHD mortality/1,000 7.2 4.7 4.8 3.9 4.8
HR (95% CI)
Model 1 1 0.58 (0.29–1.17) 0.67 (0.37–1.21) 0.58 (0.38–0.89)
Model 2 1 0.56 (0.27–1.15) 0.71 (0.39–1.29) 0.66 (0.42–1.03)
Model 3 1 0.57 (0.28–1.16) 0.75 (0.41–1.37) 0.71 (0.45–1.11)
Model 4 1 0.61 (0.30–1.25) 0.74 (0.41–1.36) 0.75 (0.48–1.17)
All-cause mortality
Deaths, n 185 70 80 295 630
Deaths/1,000 37.2 32.7 24.0 22.0 26.4
HR (95% CI)
Model 1 1 0.81 (0.62–1.07) 0.65 (0.50–0.85) 0.62 (0.51–0.74)
Model 2 1 0.79 (0.60–1.05) 0.71 (0.54–0.93) 0.70 (0.58–0.85)
Model 3 1 0.81 (0.61–1.07) 0.74 (0.57–0.97) 0.75 (0.61–0.90)
Model 4 1 0.82 (0.62–1.09) 0.73 (0.56–0.96) 0.75 (0.62–0.91)
Model 1 = age and region.
Model 2 = Model 1 plus alcohol intake, smoking history, plasma vitamin C, social class, total cholesterol, high-density lipoprotein cholesterol, triglyce-
rides, systolic blood pressure, waist circumference, forced expiratory volume in 1 second, estimated glomerular filtration rate, depression, and diabetes
mellitus.
Model 3 = Model 2 plus C-reactive protein, von Willebrand factor, and D-dimer.
Model 4 = Model 2 plus N-terminal pro-brain natriuretic peptide.
HR = Hazard Ratio; CI = Confidence Interval.
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